Results
31
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
31 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
541974 | ₹834.15 | 7.3% | 122.3% | ₹49.1b | n/a | PE118.1x | E39.0% | 0.05% | Food, Beverage & Tobacco | ||
VENUSPIPES | ₹2,207.05 | 8.6% | 48.7% | ₹42.8b | ₹2,529.60 | PE46.6x | E29.3% | 0.05% | Materials | ||
UDS | ₹324.60 | 3.7% | n/a | ₹21.7b | ₹410.33 | PE27x | E36.1% | n/a | Commercial Services | ||
524164 | ₹434.10 | 12.1% | 16.9% | ₹23.5b | ₹471.00 | PE21.5x | E22.2% | 1.2% | Pharmaceuticals & Biotech | ||
DIAMONDYD | ₹874.75 | 10.9% | -0.9% | ₹20.9b | ₹1,066.00 | PE42.5x | E25.2% | 0.2% | Food, Beverage & Tobacco | ||
531120 | ₹53.85 | 1.6% | -2.9% | ₹45.5b | ₹80.00 | PE15.1x | E20.1% | n/a | Capital Goods | ||
YATHARTH | ₹476.40 | 7.7% | 26.6% | ₹41.3b | ₹639.00 | PE32.5x | E23.0% | n/a | Healthcare | ||
KRSNAA | ₹726.90 | 9.3% | 28.0% | ₹23.5b | ₹892.00 | PE39x | E36.9% | 0.3% | Healthcare | ||
EKC | ₹190.68 | 20.8% | 69.9% | ₹19.4b | ₹158.00 | PE20.3x | E27.5% | 0.4% | Materials | ||
STAR | ₹1,276.75 | 8.3% | 206.1% | ₹117.3b | ₹1,219.33 | PS2.8x | E98.3% | 0.2% | Pharmaceuticals & Biotech | ||
RITES | ₹661.85 | -1.0% | 39.7% | ₹159.0b | ₹708.75 | PE37.3x | E23.5% | 2.7% | Commercial Services | ||
PPLPHARMA | ₹185.19 | -0.8% | 85.7% | ₹243.2b | ₹197.50 | PE884.4x | E73.5% | 0.06% | Pharmaceuticals & Biotech | ||
NIITMTS | ₹463.85 | 2.5% | 22.0% | ₹63.0b | ₹548.33 | PE28.9x | E18.3% | 1.2% | Consumer Services | ||
ORCHPHARMA | ₹1,398.50 | -0.8% | 140.8% | ₹71.3b | ₹1,525.33 | PE63.3x | E43.7% | n/a | Pharmaceuticals & Biotech | ||
500163 | ₹5,847.80 | 33.2% | 169.6% | ₹274.0b | ₹4,689.00 | PE35.5x | E23.8% | 1.0% | Food, Beverage & Tobacco | ||
TARSONS | ₹465.30 | -4.4% | -9.9% | ₹25.1b | ₹551.25 | PE67.5x | E27.5% | 0.4% | Pharmaceuticals & Biotech | ||
TITAGARH | ₹1,449.60 | 3.7% | 107.7% | ₹198.7b | ₹1,798.20 | PE66.5x | E30.1% | 0.06% | Capital Goods | ||
SCHAND | ₹230.10 | 5.7% | 14.8% | ₹7.9b | ₹312.00 | PE15.6x | E31.6% | 1.3% | Media | ||
IRB | ₹64.76 | 2.9% | 146.2% | ₹391.1b | ₹72.00 | PE63.9x | E32.0% | 0.5% | Capital Goods | ||
KPIL | ₹1,217.60 | -2.8% | 91.9% | ₹200.1b | ₹1,473.87 | PE40.6x | E29.0% | 0.7% | Capital Goods | ||
506655 | ₹987.90 | 1.9% | 94.6% | ₹68.4b | ₹945.22 | PE57x | E33.3% | 0.5% | Materials | ||
FUSION | ₹290.00 | -4.4% | -51.1% | ₹28.6b | ₹446.80 | PE8.4x | E24.7% | n/a | Diversified Financials | ||
533286 | ₹405.95 | -4.2% | 99.9% | ₹82.6b | ₹484.50 | PE23x | E36.5% | 1.5% | Materials | ||
JINDALSTEL | ₹949.65 | 4.5% | 44.8% | ₹972.9b | ₹1,021.13 | PE17.3x | E24.1% | 0.2% | Materials |